High response rate to low‐dose rituximab plus high‐dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia - Concepedia

Concepedia

Publication | Closed Access

High response rate to low‐dose rituximab plus high‐dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia

68

Citations

24

References

2013

Year

David Gómez‐Almaguer, Luz Tarín‐Arzaga, Brizio Moreno‐Jaime, José Carlos Jaime‐Pérez, Adrián Alejandro Ceballos‐López, Guillermo J. Ruíz‐Argüelles, Guillermo J. Ruiz‐Delgado, Olga Graciela Cantú‐Rodríguez, Cesar Homero Gutiérrez‐Aguirre, Mónica Sánchez‐Cárdenas

European Journal Of Haematology

Abstract

The combination of low-dose rituximab and high-dose dexamethasone as frontline therapy for adults with primary immune thrombocytopenia was effective and had a high overall response rate and a low incidence of relapse.

References

	Year	Citations

Page 1